GB201910666D0 - Novel form of compounds - Google Patents

Novel form of compounds

Info

Publication number
GB201910666D0
GB201910666D0 GBGB1910666.5A GB201910666A GB201910666D0 GB 201910666 D0 GB201910666 D0 GB 201910666D0 GB 201910666 A GB201910666 A GB 201910666A GB 201910666 D0 GB201910666 D0 GB 201910666D0
Authority
GB
United Kingdom
Prior art keywords
compounds
novel form
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1910666.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enterprise Therapeutics Ltd
Original Assignee
Enterprise Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enterprise Therapeutics Ltd filed Critical Enterprise Therapeutics Ltd
Priority to GBGB1910666.5A priority Critical patent/GB201910666D0/en
Publication of GB201910666D0 publication Critical patent/GB201910666D0/en
Priority to PCT/GB2020/051781 priority patent/WO2021014169A1/en
Ceased legal-status Critical Current

Links

GBGB1910666.5A 2019-07-25 2019-07-25 Novel form of compounds Ceased GB201910666D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1910666.5A GB201910666D0 (en) 2019-07-25 2019-07-25 Novel form of compounds
PCT/GB2020/051781 WO2021014169A1 (en) 2019-07-25 2020-07-24 Crystalline form of 4-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]-n-cyclohexyl-pyridine-2-carboxamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1910666.5A GB201910666D0 (en) 2019-07-25 2019-07-25 Novel form of compounds

Publications (1)

Publication Number Publication Date
GB201910666D0 true GB201910666D0 (en) 2019-09-11

Family

ID=67990561

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1910666.5A Ceased GB201910666D0 (en) 2019-07-25 2019-07-25 Novel form of compounds

Country Status (2)

Country Link
GB (1) GB201910666D0 (en)
WO (1) WO2021014169A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050176767A1 (en) * 2003-10-30 2005-08-11 Laval Chan Chun Kong Pyridine carboxamide and methods for inhibiting HIV integrase
GB201801355D0 (en) * 2018-01-26 2018-03-14 Enterprise Therapeutics Ltd Compounds

Also Published As

Publication number Publication date
WO2021014169A1 (en) 2021-01-28

Similar Documents

Publication Publication Date Title
GB201902327D0 (en) Novel compounds
GB201905375D0 (en) Novel compounds
GB201912674D0 (en) Novel compounds
GB201905371D0 (en) Novel compounds
GB201918587D0 (en) Novel compounds
IL290324A (en) Compositions of trofinetide
IL289627A (en) Novel pfar-inhibiting compounds
GB201913548D0 (en) Novel compounds
GB201913701D0 (en) Composition of matter
GB201804905D0 (en) Cataltic synthesis of biarylic compounds
GB201910665D0 (en) Novel form of compounds
GB201910666D0 (en) Novel form of compounds
GB201910664D0 (en) Novel forms of compound
PT3901141T (en) Novel form of isoquinolinesulfonamide
GB201918076D0 (en) Novel compounds
GB201917863D0 (en) Novel compounds
GB201917320D0 (en) Novel compounds
GB201915129D0 (en) Novel compounds
GB201914623D0 (en) Novel compounds
GB201914624D0 (en) Novel compounds
GB201912865D0 (en) Novel compounds
GB201912836D0 (en) Novel compounds
GB201911960D0 (en) Novel compounds
GB201911777D0 (en) Novel compounds
GB201911781D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)